Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Massachusetts??? Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials July 31, 2017 DBV Technologies Crashed as Allergy Drug Flunked Phase III Test October 22, 2017 Champions Oncology Surges After Inking R&D Deal With This Drug Giant August 20, 2017